BeOne Medicines Announces Fourth Quarter and Full Year 2025 Financial Results, Highlighting Global Success of BRUKINSA and Foundational Oncology Leadership

Contributed by: Business Wire

Logo

Business Wire logo

Tags

Biotechnology
Pharmaceutical
Health
Oncology
BRUKINSA

More Like This

Business Wire logo

BeOne Medicines Announces Third Quarter 2025 Financial Results and Business Updates

Business Wire logo

BeOne Medicines Announces Second Quarter 2025 Financial Results and Business Updates

Business Wire logo

BeiGene Announces First Quarter 2025 Financial Results and Business Updates

(Graphic: Business Wire)

BeiGene Announces Fourth Quarter and Full Year 2024 Financial Results and Business Updates

Business Wire logo

BeiGene Reports First Quarter 2024 Financial Results and Business Updates

Business Wire logo

BeiGene Reports Fourth Quarter and Full Year 2023 Financial Results and Business Updates

(Graphic: Business Wire)

BeiGene Enters Next Phase of Global Growth with Announcement of Second Quarter 2024 Financial Results and Corporate Updates

PR Newswire associated0

Cboe Global Markets Reports Results for Fourth Quarter 2024 and Full Year